Mitchell et al. have reported that expression of miR-141, the first miRNA reported as a potential diagnostic marker in PCa, correlates significantly with serum PSA levels and could detect individuals with advanced metastatic prostate cancer with 60% sensitivity and 100% specificity [122]. Here, KLK3 is linked to posterior cortical atrophy.